Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
28,889,565
-
Share change
-
-1,194,584
-
Total reported value
-
$113,249,697
-
Put/Call ratio
-
129%
-
Price per share
-
$3.92
-
Number of holders
-
119
-
Value change
-
-$5,662,704
-
Number of buys
-
48
-
Number of sells
-
48
Institutional Holders of INOVIO PHARMACEUTICALS INC - COM NEW (INO) as of Q2 2018
As of 30 Jun 2018,
INOVIO PHARMACEUTICALS INC - COM NEW (INO) was held by
119 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,889,565 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, WASATCH ADVISORS INC, ARK Investment Management LLC, NORTHERN TRUST CORP, GEODE CAPITAL MANAGEMENT, LLC, GUGGENHEIM CAPITAL LLC, DEUTSCHE BANK AG\, and CITADEL ADVISORS LLC.
This page lists
119
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.